Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,681 total articles
Aveanna Healthcare Holdings Inc. announced a successful repricing of its first lien and revolving credit facilities, resulting in a 50 basis point reduction in interest margins, with potential for an additional 25 basis point reduction upon credit rating upgrades. This refinancing move strengthens Aveanna's balance sheet and supports ongoing strate…
CPS Technologies Corp. has priced a registered direct offering of 1.2 million common shares at $8.00 per share, raising approximately $9.6 million before expenses. The proceeds will be used for general corporate purposes including working capital, capital expenditures, and commercialization of developing technologies. The offering is conducted unde…
BioCardia, Inc. announced that Japan's PMDA has issued a Consultation Record supporting the regulatory submission of CardiAMP Cell Therapy for ischemic heart failure with reduced ejection fraction (HFrEF). This follows successful clinical trials and confirms alignment on remaining questions ahead of submission. BioCardia plans to submit its applica…
PROCEPT BioRobotics announced the completion of enrollment for the randomized WATER IV study comparing Aquablation therapy to radical prostatectomy, and obtained FDA IDE approval for a second randomized study evaluating Aquablation therapy versus active surveillance in prostate cancer patients. Both studies aim to assess long-term disease control a…
Immutep Limited announced positive clinical data from an analysis of five trials showing that eftilagimod alfa (efti), an antigen-presenting cell activator, combined with standard-of-care therapies, significantly improves overall survival in late-stage cancer patients. The data indicate immune activation correlates with clinical benefit across vari…
Monster Beverage Corporation announced that its senior management team will participate in a live fireside chat at the dbAccess Global Consumer Conference on June 4, 2026, detailing ongoing developments in its energy drink and alcoholic beverage segments.
ZenaTech, Inc. announces the development of ZenaWorx, a LiDAR-based Virtual Design and Construction progress monitoring software designed to enhance accuracy and reduce costs in AI data center construction. The software integrates drone-captured data analytics to provide precise 3D digital maps for tracking construction progress and deviations. A p…
Nordic American Tankers Ltd (NAT) reported a net result of $46.3 million for Q1 2026, surpassing its full-year 2025 net result. The company declared a dividend of $0.22 per share for Q1, marking 115 consecutive quarters of dividend payments. Approximately 90% of its fleet is booked at significantly improved daily rates compared to the previous quar…
Kelly Services, a global provider of workforce strategy and solutions, has announced its upcoming participation in three investor conferences in June 2026. The company will present and hold one-on-one meetings with investors at the Baird Global Consumer, Technology & Services Conference, East Coast IDEAS Conference, and Sidoti Small-Cap Virtual Con…
FirstService Corporation’s subsidiary, Century Fire Protection, has acquired GSC Fire & Security and Titan Fire Protection, significantly expanding its fire protection services in the growing Sun Belt region of the U.S. Both companies’ management teams retain minority equity stakes and operational roles, supporting seamless integration. The acquisi…
Compass Therapeutics, a clinical-stage oncology-focused biopharmaceutical company, announced its participation in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference in June 2026, providing investor presentations and one-on-one meetings to discuss its pipeline of antibody-based therapeutics targetin…
TG Therapeutics, a commercial-stage biotechnology company specializing in B-cell disease treatments, announced that CEO Michael S. Weiss will participate in the upcoming Jefferies Global Healthcare Conference. The event includes a fireside chat to be webcast live, providing updates on company progress and developments. TG Therapeutics markets BRIUM…
BOS Better Online Solutions Ltd. reported $11.4 million in revenue and $765,000 net income for Q1 2026. Despite a decrease in revenue compared with Q1 2025 partly due to one-off transaction last year, gross margin improved to 24.9%. The company expanded its presence in India via an exclusive distribution deal and gained full ownership of a defense-…
Exodus Movement announces that its XO Swap cross-chain swap aggregator has been integrated into Bitget Wallet, one of the world's largest self-custody crypto wallets with over 90 million users. This integration enhances cross-chain trading by providing deeper liquidity, competitive rates, and faster execution across nearly 100 blockchains, empoweri…
Dyadic International, a US-based biotechnology company, announced a collaboration with Scripps Research to evaluate new monoclonal antibodies and vaccine candidates targeting hantaviruses, including the Andes virus which causes severe respiratory disease. Leveraging Dyadic’s proprietary C1 microbial protein production platform, the partnership aims…
Zenas BioPharma announced the submission of a Biologics License Application (BLA) to the U.S. FDA for obexelimab, a novel bifunctional monoclonal antibody intended to treat Immunoglobulin G4-Related Disease (IgG4-RD). The submission follows positive results from the Phase 3 INDIGO registrational trial, demonstrating significant reduction in disease…
Ingredion Incorporated announces a strategic joint venture and equity investment in Sanstar Limited, enhancing its capabilities in the fast-growing Indian specialty starch and pharmaceutical ingredient markets. This partnership combines Ingredion's global innovation and formulation expertise with Sanstar's local manufacturing strengths to serve pha…
NRx Pharmaceuticals' strategic partner Emobot has presented clinical validation data for EMOCARE, a smartphone-based passive monitoring tool for depression, demonstrating high concordance with established clinician-rated scales. EMOCARE is being integrated across NRx's Hope Therapeutics interventional psychiatry clinics to provide continuous, real-…
G-III Apparel Group, Ltd. will release its first quarter fiscal 2027 earnings before market open on June 5, 2026. Management will host a conference call to discuss the results and answer investor questions. The company highlights its portfolio of over 30 fashion brands, including owned and licensed names such as DKNY, Calvin Klein, and Tommy Hilfig…
NovaBridge Biosciences announced its senior management will present at the 2026 Jefferies Global Healthcare Conference, highlighting its advancing pipeline including givastomig, VIS-101, and collaborations. The presentation underscores the company’s progress in developing novel therapies for cancer and retinal diseases, building investor confidence…
Gogo Inc. announced that Airshare, a U.S.-based aircraft management and charter services operator, will equip its fleet of Embraer Phenom 300 jets with the Gogo Galileo HDX inflight connectivity system. The system offers high-speed, low-latency internet powered by a low-earth-orbit satellite network, enabling passengers to use multiple bandwidth-in…
REalloys Inc. (NASDAQ: ALOY) announced a non-binding Memorandum of Understanding with Ramaco Resources to explore a long-term partnership for sourcing and commercializing rare earth and critical mineral products from Ramaco's Brook Mine in Wyoming. The collaboration aims to integrate coal-hosted rare earth feedstocks into REalloys' phased commercia…
Tilray Brands, Inc. announced the launch of Cherry Ztripez, a new indica-dominant craft cannabis strain under its Broken Coast brand. The product features high-quality, small-batch cultivation and refined packaging targeting the summer cannabis market in Canada. This launch supports Tilray's position in the premium cannabis segment and leverages th…
Tiziana Life Sciences announced it will present at the Jefferies Global Healthcare Conference in New York, providing updates on its clinical programs, notably its lead candidate, intranasal foralumab, which is currently in Phase 2a trials for multiple sclerosis. The company highlights its innovative immunotherapy approach with potential broader app…
Ambow Education Holding Ltd. (NYSE American: AMBO) has launched the HybriU™ Partner Portal, an AI-powered channel partner program designed to scale global distribution of its AI-driven phygital product suite across education, events, conferences, and enterprise markets. The portal offers sales partners an integrated platform for lead and order mana…
